In each meeting of the Working Party on Manufactured Nanomaterials (WPMN),
the delegations have an opportunity to provide their developments on the safety
of manufactured nanomaterials, so called “Tour de Table.” An earlier version of
this document was originally provided to the 5th meeting held 4-6 March 2009 in
Paris, France. This document includes an update of the status of the work of
the WPMN (Section I) and compiles information provided by member countries and
other delegations on current developments on the safety of manufactured
nanomaterials (section II) in their countries or organisations. There are also
written reports on current activities related to nanotechnologies/
nanomaterials in other International Organisations including the International
Organisation for Standardisation, the Food and Agriculture Organisation of the
United Nations and the World Health Organisation (section III).
This is intended to provide delegations and other stakeholders with a
“snapshot” of information on activities related to manufactured nanomaterials,
as well as other activities on nanotechnologies, at the national and
international level. This “snapshot” was current at the time of the 6th meeting
of the WPMN (October 2009). The Working Party endorsed this document at its 6th
Meeting on October 2009.
The purpose of this document (the Tour de Table) is to give each delegation
the opportunity to describe recent or planned national initiatives and/or
events related to the safety of nanomaterials. This will facilitate the
implementation of the projects of the Working Party on Manufactured
Nanomaterials (WPMN) by allowing delegations to share their experiences and
preoccupations with respect to safety, and will identify opportunities for
future co-operation and co-ordination.
In considering the Tour de Table, each delegation was invited to prepare a
short written paper. It was recommended that the information in these papers be
organised, where possible, under the headings identified below, while
recognising that not all delegations would be able to supply information under
1. Any national regulatory developments on human health and environmental
safety including recommendations or discussions related to adapting existing
regulatory systems or the drafting of laws/ regulations/ guidance materials;
2. Developments related to voluntary or stewardship schemes;
3. Information on any risk assessment decisions;
4. Information on any developments related to good practice documents;
5. Research programmes or strategies designed to address human health and/
or environmental safety aspects of nanomaterials;
6. Information on any public/ stakeholder consultation.
7. Additional Information: Delegations may wish to provide any additional
related information, e.g., any consideration of the benefits of
nanotechnologies and consideration of ethical implications.